These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 8459648)
1. Enhanced production of platelet-activating factor in stimulated rat leukocytes caused by the blockade of lysophospholipid acylation. Naraba H; Imai Y; Hayashi M; Oh-ishi S Jpn J Pharmacol; 1993 Feb; 61(2):109-13. PubMed ID: 8459648 [TBL] [Abstract][Full Text] [Related]
2. Activation of phospholipase A2 and acylation of lysophospholipids: the major regulators for platelet activating factor production in rat neutrophils. Naraba H; Imai Y; Kudo I; Nakagawa Y; Oh-ishi S J Biochem; 1995 Aug; 118(2):442-7. PubMed ID: 8543583 [TBL] [Abstract][Full Text] [Related]
3. Enhanced production of platelet-activating factor in stimulated rat leukocytes pretreated with triacsin C, A novel acyl-coA synthetase inhibitor. Hayashi M; Imai Y; Naraba H; Tomoda H; Omura S; Oh-ishi S Biochem Biophys Res Commun; 1992 Nov; 188(3):1280-5. PubMed ID: 1445360 [TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of arachidonic acid on platelet-activating factor production in rat neutrophils. Naraba H; Ueno A; Matsumoto H; Oh-ishi S Eur J Pharmacol; 1996 Apr; 302(1-3):117-21. PubMed ID: 8790999 [TBL] [Abstract][Full Text] [Related]
5. Ether lysophospholipid-induced production of platelet-activating factor in human polymorphonuclear leukocytes. Sugiura T; Fukuda T; Masuzawa Y; Waku K Biochim Biophys Acta; 1990 Dec; 1047(3):223-32. PubMed ID: 2123719 [TBL] [Abstract][Full Text] [Related]
6. The acyl-CoA synthetase inhibitor triacsin C enhanced eicosanoid release in leukocytes. Oh-ishi S; Yamaki K; Abe M; Tomoda H; Omura S Jpn J Pharmacol; 1992 Jul; 59(3):417-8. PubMed ID: 1434135 [TBL] [Abstract][Full Text] [Related]
7. Possible mechanisms for the differential effects of high linoleate safflower oil and high alpha-linolenate perilla oil diets on platelet-activating factor production by rat polymorphonuclear leukocytes. Oh-hashi K; Takahashi T; Watanabe S; Kobayashi T; Okuyama H J Lipid Mediat Cell Signal; 1997 Dec; 17(3):207-20. PubMed ID: 9524928 [TBL] [Abstract][Full Text] [Related]
8. Hydrocortisone and 'macrocortin' inhibit the zymosan-induced release of lyso-PAF from rat peritoneal leucocytes. Parente L; Flower RJ Life Sci; 1985 Apr; 36(13):1225-31. PubMed ID: 3838566 [TBL] [Abstract][Full Text] [Related]
9. Translocation of exogenous platelet-activating factor and its lyso-compound through plasma membranes is a rate-limiting step for their metabolic conversions into alkylacylglycerophosphocholines in rabbit platelets and guinea-pig leukocytes. Tokumura A; Tsutsumi T; Yoshida J; Tsukatani H Biochim Biophys Acta; 1990 May; 1044(1):91-100. PubMed ID: 2340312 [TBL] [Abstract][Full Text] [Related]
10. MgATP has different inhibitory effects on the use of 1-acyl-lysophosphatidylcholine and lyso platelet-activating factor acceptors by neuronal nuclear acetyltransferase activities. Baker RR; Chang H Biochim Biophys Acta; 1998 Jun; 1392(2-3):351-60. PubMed ID: 9630721 [TBL] [Abstract][Full Text] [Related]
11. Cooperation between platelets and neutrophils for paf-acether (platelet-activating factor) formation. Coƫffier E; Delautier D; Le Couedic JP; Chignard M; Denizot Y; Benveniste J J Leukoc Biol; 1990 Mar; 47(3):234-43. PubMed ID: 2307906 [TBL] [Abstract][Full Text] [Related]
12. Biosynthesis of platelet-activating factor (PAF) in human polymorphonuclear leucocytes. The role of lyso-PAF disposal and free arachidonic acid. Garcia MC; Fernandez-Gallardo S; Gijon MA; Garcia C; Nieto ML; Sanchez Crespo M Biochem J; 1990 May; 268(1):91-8. PubMed ID: 1693077 [TBL] [Abstract][Full Text] [Related]
13. Enzymatic studies of lyso platelet-activating factor acylation in human neutrophils and changes upon stimulation. Venable ME; Olson SC; Nieto ML; Wykle RL J Biol Chem; 1993 Apr; 268(11):7965-75. PubMed ID: 8463317 [TBL] [Abstract][Full Text] [Related]
14. Platelet-leukocyte interaction in adhesion to endothelial cells induced by platelet-activating factor in vitro. Hirafuji M; Shinoda H Br J Pharmacol; 1991 Jun; 103(2):1333-8. PubMed ID: 1884095 [TBL] [Abstract][Full Text] [Related]
15. Generation of the precursor (lyso-PAF) of platelet-activating factor via a CoA-dependent transacylase. Blank ML; Fitzgerald V; Smith ZL; Snyder F Biochem Biophys Res Commun; 1995 May; 210(3):1052-8. PubMed ID: 7763233 [TBL] [Abstract][Full Text] [Related]
16. Release of platelet-activating factor (PAF-acether) and 2-lyso PAF-acether from three cell types. Benveniste J; Roubin R; Chignard M; Jouvin-Marche E; Le Couedic JP Agents Actions; 1982 Dec; 12(5-6):711-3. PubMed ID: 7164945 [TBL] [Abstract][Full Text] [Related]
17. Selective inhibitors of a PAF biosynthetic enzyme lysophosphatidylcholine acyltransferase 2. Tarui M; Shindou H; Kumagai K; Morimoto R; Harayama T; Hashidate T; Kojima H; Okabe T; Nagano T; Nagase T; Shimizu T J Lipid Res; 2014 Jul; 55(7):1386-96. PubMed ID: 24850807 [TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor. Camussi G; Bussolino F; Salvidio G; Baglioni C J Exp Med; 1987 Nov; 166(5):1390-404. PubMed ID: 3119758 [TBL] [Abstract][Full Text] [Related]
19. Biosynthesis of Paf-acether (platelet-activating factor). VII. Precursors of Paf-acether and acetyl-transferase activity in human leukocytes. Jouvin-Marche E; Ninio E; Beaurain G; Tence M; Niaudet P; Benveniste J J Immunol; 1984 Aug; 133(2):892-8. PubMed ID: 6736649 [TBL] [Abstract][Full Text] [Related]
20. Substrate specificities of neuronal nuclear acetyltransferases involved in the synthesis of platelet-activating factor: differences in the use of 1-alkyl and 1-acyl lysophospholipid acceptors. Roy Baker R; Chang H Biochim Biophys Acta; 1998 Feb; 1390(2):215-24. PubMed ID: 9507140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]